Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LTX-401, targets the Golgi apparatus, and is an oncolytic amino acid derivative.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
100 mg | 待询 | 待询 | ||
500 mg | 待询 | 待询 |
产品描述 | LTX-401, targets the Golgi apparatus, and is an oncolytic amino acid derivative. |
体外活性 | LTX-401 displays the highest cytotoxic activity against the human malignant melanoma cell line MDA-MB-435S (13.5 μM), and is least active against the human hepatocellular carcinoma cell line HEPG2 (35.4 μM). For the remaining cell lines, LTX-401 exhibits similar IC50 values, varying slightly within the range of 19-32 μM. No in vitro hemolytic activity against RBCs is observed using the same concentrations required for the induction of cell death in cancer cell lines. A 50% hemolysis is observed using higher concentrations of LTX-401 (400 μg/mL=1087 μM)[1].LTX-401, an oncolytic amino acid derivative, targets the Golgi apparatus[2].?LTX-401 effectively reduces the viability of several tumor cell lines in vitro, with a similar degree of cytotoxicity against non-malignant cell lines such as HUV-EC-C endothelial cells, HaCat keratinocytes and MRC-5 fibroblasts. |
体内活性 | The majority ?of the animals demonstrate a complete and lasting tumor regression after intratumoral treatment with LTX-401.?Samples are collected from selected animals in the treatment group and control group on days 2 and 7 post-treatment with a single i.t injection.?The immunolabelling of tumor tissue with anti-CD3 antibody reveals that a majority of the infiltrating cells are CD3+ T cells, whereas tumors injected with vehicle only exhibit tumors with a viable tumor tissue, with minimal necrosis and few lymphocytes[1]. |
别名 | LTX-401 dihydrochloride |
分子量 | 440.45 |
分子式 | C23H35Cl2N3O |
CAS No. | T13759 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
LTX-401 dihydrochloride (1262851-70-6 free base) T13759 Others LTX-401 LTX-401 dihydrochloride 1262851-70-6 LTX401 Dihydrochloride LTX401 dihydrochloride (1262851706 free base) LTX 401 LTX-401 Dihydrochloride 1262851-70-6 free base LTX 401 dihydrochloride (1262851 70 6 free base) LTX 401 Dihydrochloride LTX401 Inhibitor inhibitor inhibit